Roche, Atea Pharmaceuticals partner on COVID-19 oral treatment October 27, 2020 Auto Bot Clinical Development 0 The two companies are working together to develop AT-527, an orally administered, direct-acting antiviral therapy for patients diagnosed with COVID-19.
